Reneo Pharmaceuticals, Inc.(NASDAQ:RPHM) 
Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patie...
Website: http://reneopharma.com
Founded: 2014
CEO: Gregory J. Flesher
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-04-09
P
O 1.68
H 1.72
L 1.68
C 1.70
V 43,653
10EMA 1.70
20EMA 1.70
60EMA 1.70
120EMA 1.70
250EMA 1.70